Ledger.Open graph →
SEC Form D · filed December 5, 2022

ImmuneSensor Therapeutics, Inc

Offering
$20.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DALLAS, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Qingsong Li · Dallas, TXExec · DirectorZhi Hong · Dallas, TXDirectorErnest Wong · Vancouver, British Columbia, CanadaExec · DirectorNing Zhang · Liaoning Province, IsraelDirectorQingsong Li · Dallas, TXExec · DirectorZhi Hong · Dallas, TXDirectorErnest Wong · Vancouver, British Columbia, CanadaExec · DirectorNing Zhang · Dallas, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗